NOTE: See the Table of Materials for details related to all materials, reagents, and software used in this protocol.
1. Device construction
2. Cell lines: cultivation, seeding, and treatment
3. Device operation
4. Cell viability assay
The final PDT device, named the PhotoACT, included a dark chamber to allocate up to four multiwell microplates, with its upper interior surface equipped with a set of 30 scattered LEDs programmed to emit distinct spectrums of visible light (Figure 3 and Supplemental File 6). The device was built using two associated boxes: an internal box designed as a dark chamber for the PDT assays, and an external box to cover the internal chamber and hold the control unit (Figure 1B). The internal box was painted black (Figure 1D) and composed of a tape model of LED RGB WS2812 (or WS281B) with 30 LEDs and of 1 m length (which was later cut into three pieces) and 9 watts, which holds a built-in processor. This apparatus allowed a more controlled utilization and, consequently, more accurate color emission. The 30 LEDs were equally distributed over the entire upper interior surface of the PDT chamber by three parallel tapes with 10 LEDs each (Figure 1E). A homogeneous light incidence was established due to the low reflectivity of the black interior surfaces and the uniform distribution of LED configuration. A TSL2561 brightness sensor was also incorporated in the bottom center of the internal box to indicate the light incidence and serve as a quality control tool, guaranteeing irradiation uniformity inside the dark chamber (Supplemental Table S1) and monitoring the power of the LED system, which is known to have a certain number of hours of useful life (Figure 1F). The external box is a structure that covers the internal box, composed of six MDF parts, painted gray, and laser-cut for a perfect fit (Figures 1A,B). The control unit was designed using online software31, 3D printed with polylactic acid as a single part using a 3D printer, and painted gray. It holds all the electronics components, including a display, potentiometers, buttons, and a buzzer (Figure 1I and Figure 2).
To enable independent light incidence adjustments, the ESP32 controller board was selected to integrate the control unit (Figure 2). This configuration should allow a USB interface for programming, bluetooth, Wi-Fi, dual core processor, numerous ports, and the ability to communicate with an inter-integrated circuit (I2C), a serial peripheral interface (SPI), and other interfaces. To operate the system, a program was written in C language through an integrated development environment (IDE). The code structure32 is based on FreeRTOS, a free, real-time operational system supported by ESP32 controller board. The referred logic allows independent applications programming, which can be processed by ESP32 in echeloned or parallel approaches, making the project and its maintenance, improvement, and update processes much more versatile and secure.
The interface between the machine and the operator is user-friendly and consisted of a liquid crystal display (LCD), potentiometers, buttons, and a buzzer (Figure 3 and Supplemental File 6). The small, 16 mm x 2 mm (columns vs. lines) LCD had a built-in HD44780 controller with an I2C communication protocol, which confers the ease of installation and transmission versatility, respectively. The preliminary setup includes RGB and time adjustments by the operator. The light magnitude and color configuration can be adjusted using the potentiometers, which modify the intensity (0 to 255) of the three basic color components-RGB. These adjustments can result in several color compositions addressed in the international RGB colors table33. Each RGB composition owns a specific wavelength, which must be adjusted according to the PS used in the PDT experiment; the absorbance curve of the PS and the wavelength of the irradiation must be overlapped for the photoactivation to occur satisfactorily (Supplemental Figure S1). Along the process, the operation status with the time left and light incidence information can be accessed on the LCD.
At the end of the programmed time, the electronics system turned all the LEDs off, emitted an audible warning, and showed on the display the total amount of energy per area (J/cm²), which was calculated by multiplying the constant value of irradiance by the operation time in seconds. This digital model presented a broad range of detection levels (limits between 0.1 and 40,000+ lux), an I2C interface, and a low intensity of electric current (0.5 mA and 15 µA in operation and standby status, respectively).
As a proof of concept, the device was used to enhance the cytotoxic effect of verteporfin in 2D HeLa cell culture after light exposure of 1 h (49.1 ± 0.6 J/cm2). As shown in Figure 4A, the GI50 value was 3.1 µM for the light condition and 13.8 µM for the dark condition. Thus, the 4.4-fold shift comparing the conditions validated the use of verteporfin as a PS and the applicability of PhotoACT to PDT assays. To validate the use of the prototype described in this work, a commercial PDT device was used under the same experimental conditions, including a PS, cells, and fluence, and the results compared. As shown in Figure 4B, both devices photoactivated verteporfin equally, enhancing the cytotoxic effect. These results confirmed the applicability of this in house-built PDT device (Figure 4A,B). Finally, the ROS-mediated cell death triggered by verteporfin after light exposure was confirmed by flow cytometry using DCFDA assay (Figure 4C,D).
Figure 1: PhotoACT construction and assembly instructions. Detailed illustration of the construction of, drilling, painting, mounting, and accessorizing components into the device. The panel shows a step-by-step guide to build the device. Abbreviation: LED = light-emitting diode. Please click here to view a larger version of this figure.
Figure 2: The control unit construction and electronic installation instructions. Zoomed-in view drawing of exploded control unit and detailed scheme of electronic connections at ESP32 controller board ports with connections and components used in the prototype. Please click here to view a larger version of this figure.
Figure 3: PhotoACT representation. Assembly drawing of the final product design with bill of materials, labelling balloons, and detailed view of the upper interior LEDs. The figure allows to identify parts and components of the prototype. Abbreviations: MDF = medium-density fiberboard; LED = light-emitting diode. Please click here to view a larger version of this figure.
Figure 4: In vitro phototoxicity of verteporfin and ROS generation. (A,B) Cell viability assay performed using the MTT method: the assays were conducted to evaluate the cytotoxic profile of the photosensitizer verteporfin at different concentrations.HeLa cells were treated for 24 h with different concentrations of verteporfin (0.045-24 µM), exposed to light (PhotoACT (A) or commercial PDT equipment (B)) or dark conditions, and then subjected to the MTT assay. Both conditions showed a decreased cell viability at higher concentrations of verteporfin, but the light exposure-obtained from PDT assays-enhanced the cytotoxic profile of the PS, which implies that PDT enhances the cytotoxicity of verteporfin. The viability curves were fitted using GraphPad Prism 6 software. (C,D) HeLa cells were treated for 24 h with low and high concentrations of verteporfin (0.187 µM and 6 µM) and then exposed to light (PhotoACT) or dark conditions. Intracellular ROS levels were measured after irradiation by flow cytometry using DCFDA probe (incubation for 30 min at 1 µM). A right shift among the histograms implied higher fluorescence intensity because of a higher intracellular accumulation of DCF, and thus, greater ROS levels. The results showed no relevant difference in ROS levels in the dark condition (C) but showed a dose-response increase in ROS levels after verteporfin photoactivation (D). Abbreviations: ROS = reactive oxygen species; DCF = 2',7'-dichlorofluorescein; DCFDA = 2',7'-dichlorohydrofluorescein diacetate. Please click here to view a larger version of this figure.
Figure 5: The device's decision flowchart: preliminary setup and operation troubleshooting. Please click here to view a larger version of this figure.
Supplemental Figure S1: Overlap between the absorbance curve of verteporfin and the LED emission spectrum of the device. Absorption spectrum of verteporfin with its specific absorbance peaks (x,y') and LED emission spectrum of RGB 255, 255, 255-white color (3,700K-5,000K CCT) utilized to photoactivate the photosensitizer (x,y''). The overlap between the different absorbance peaks of verteporfin and the white irradiating light corroborates the photoactivation of the photosensitizer, which was also confirmed by the biological results. Please click here to download this File.
Supplemental Table S1: Irradiation uniformity tests. Instant luminosity (lumen) measured by the brightness sensor at different points of the irradiated area. The presented results show no expressive variation, which attest the uniform irradiation of the device. Please click here to download this File.
Supplemental File 1: Vector file for cutting. Drawing (DWG) file for MDF board cutting. The file must be used for computer numerical control (CNC) cutting. Please click here to download this File.
Supplemental File 2: 3D printing file of the unit control's. Stereolithography (STL) file to 3D print the control unit of the device. Please click here to download this File.
Supplemental File 3: C programming code. Programming code developed in C language for configuring the control unit of the equipment. Please click here to download this File.
Supplemental File 4: INO programming code. Programming code developed in INO language for configuring the control unit of the equipment. Please click here to download this File.
Supplemental File 5: Compilation instructions. Markdown (MD) "READ ME" file with additional instructions for programming code compilation. Please click here to download this File.
Supplemental File 6: Design model of the device. Preview of the Standard for the Exchange of Product Data (STEP) tridimensional model file for general visualization of the prototype. Please click here to download this File.
0.5% Trypsin-EDTA (10x) | Gibco | 15400054 | Mammalian cell culture dissociation reagent |
3D printer | Flashforge | Finder model | |
96-well plates | Non-sterile, polystyrene, and high-binding surface plates with flat bottom wells used for 2D cell culture | ||
Arduino | |||
Brightness sensor | TSL2561 model with 0.1-40.000+ lux detection levels and I2C interface | ||
Buttons | |||
Buzzer | |||
Cell culture Flasks | Sterile, polystyrene, rectangular bottom flask with Tissue Culture (TC)-treated surface, canted neck and vent cap (sizes) | ||
Centrifuge Tubes | Sterile, polypropylene tubes with 15/50 mL capacity used for cell culture dilution at seeding step of the assay | ||
CO2 Incubator | |||
Controller board | ESP32 | ||
Design Software | Trimble | SketchUp | |
DMEM High Glucose | Gibco | 11965092 | DMEM (Dulbecco's Modified Eagle Medium) is a widely used basal medium for supporting the growth of many different mammalian cells. |
DMSO | Sigma-Aldrich | D4540-500ML | Dimethyl sulfoxide, ≥99.5% (GC), suitable for plant cell culture |
Fetal Bovine Serum | Gibco | 12657029 | FBS provides the best value by delivering consistency of cell growth over time and passages. |
Gentamicin (50 mg/mL) | Gibco | 15750060 | Water-soluble antibiotic drug originally purified from the fungus Micromonospora purpurea. Gentamicin acts by preventing cell culture contamination |
Hemocytometer | Neubauer patterned chamber used for cell counting at seeding step of the assay | ||
Inverted Laboratory Microscope | Leica | DM IL LED | |
Laminar Flow Hood | Cabin designed to protect the working environment from contaminants by maintaining a constant, unidirectional flow of HEPA-filtered air over the work area. Used at several steps of cell cultivation and treatment procedures | ||
LCD display | |||
LED RGB WS2812 | 5050 RGB SMD model with a built-in processor. Tape with 30 LEDs, 1 meter length and 9 watts | ||
MDF fiberboards | 3mm thickness medium-density fiberboards | ||
Microcentrifuge Tubes | Sterile, polypropylene tubes with safety lid and 1.5/2.0 mL capacity. Convenient tools for manipulating small volumes at treatment step of the assay | ||
Microplate reader | ThermoFischer | Multiskan FC Microplate Photometer designed to detect a broad wavelength range of absorbance (340-850 nm). The equipment was used to evaluate cell viability after MTT incubation. | |
MTT Reagent | Invitrogen | M6494 | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Used for cell viability assays |
Operational System | Real Time Engineers ltd. | FreeRTOS | |
P10 micripipette | Non-electronic, single-channel, 1-10 μL capacity | ||
P1000 micropipette | Non-electronic, single-channel, 10-1000 μL capacity | ||
P200 micropipette | Non-electronic, single-channel, 20-200 μL capacity | ||
PDT Equipment | LumaCare | Model LC-122 | |
Phosphate-Buffered Saline pH 7.4 | Gibco | 10010031 | Balanced salt formulation used for washing cells during cultivation and assay procedures |
Potentiometers | |||
Tips | Non-sterile, universal fit, 10/200/1000 μL maximum volumes | ||
Verteporfin | Sigma-Aldrich | SML0534-5MG | Verteporfin, ≥94% (HPLC) |
This paper describes a novel, simple, and low-cost device to perform in vitro photodynamic therapy (PDT) assays, named the PhotoACT. The device was built using a set of conventional programmable light-emitting diodes (LEDs), a liquid crystal display (LCD) module, and a light sensor connected to a commercial microcontroller board. The box-based structure of the prototype was made with medium-density fiberboards (MDFs). The internal compartment can simultaneously allocate four cell culture multiwell microplates.
As a proof of concept, we studied the cytotoxic effect of the photosensitizer (PS) verteporfin against the HeLa cell line in two-dimensional (2D) culture. HeLa cells were treated with increasing concentrations of verteporfin for 24 h. The drug-containing supernatant medium was discarded, the adherent cells were washed with phosphate-buffered saline (PBS), and drug-free medium was added. In this study, the effect of verteporfin on cells was examined either without light exposure or after exposure for 1 h to light using red-green-blue (RGB) values of 255, 255, and 255 (average fluence of 49.1 ± 0.6 J/cm2). After 24 h, the cell viability was assessed by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Experimental results showed that exposure of cells treated with verteporfin to the light from the device enhances the drug's cytotoxic effect via a mechanism mediated by reactive oxygen species (ROS). In addition, the use of the prototype described in this work was validated by comparing the results with a commercial PDT device. Thus, this LED-based photodynamic therapy prototype represents a good alternative for in vitro studies of PDT.
This paper describes a novel, simple, and low-cost device to perform in vitro photodynamic therapy (PDT) assays, named the PhotoACT. The device was built using a set of conventional programmable light-emitting diodes (LEDs), a liquid crystal display (LCD) module, and a light sensor connected to a commercial microcontroller board. The box-based structure of the prototype was made with medium-density fiberboards (MDFs). The internal compartment can simultaneously allocate four cell culture multiwell microplates.
As a proof of concept, we studied the cytotoxic effect of the photosensitizer (PS) verteporfin against the HeLa cell line in two-dimensional (2D) culture. HeLa cells were treated with increasing concentrations of verteporfin for 24 h. The drug-containing supernatant medium was discarded, the adherent cells were washed with phosphate-buffered saline (PBS), and drug-free medium was added. In this study, the effect of verteporfin on cells was examined either without light exposure or after exposure for 1 h to light using red-green-blue (RGB) values of 255, 255, and 255 (average fluence of 49.1 ± 0.6 J/cm2). After 24 h, the cell viability was assessed by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Experimental results showed that exposure of cells treated with verteporfin to the light from the device enhances the drug's cytotoxic effect via a mechanism mediated by reactive oxygen species (ROS). In addition, the use of the prototype described in this work was validated by comparing the results with a commercial PDT device. Thus, this LED-based photodynamic therapy prototype represents a good alternative for in vitro studies of PDT.
This paper describes a novel, simple, and low-cost device to perform in vitro photodynamic therapy (PDT) assays, named the PhotoACT. The device was built using a set of conventional programmable light-emitting diodes (LEDs), a liquid crystal display (LCD) module, and a light sensor connected to a commercial microcontroller board. The box-based structure of the prototype was made with medium-density fiberboards (MDFs). The internal compartment can simultaneously allocate four cell culture multiwell microplates.
As a proof of concept, we studied the cytotoxic effect of the photosensitizer (PS) verteporfin against the HeLa cell line in two-dimensional (2D) culture. HeLa cells were treated with increasing concentrations of verteporfin for 24 h. The drug-containing supernatant medium was discarded, the adherent cells were washed with phosphate-buffered saline (PBS), and drug-free medium was added. In this study, the effect of verteporfin on cells was examined either without light exposure or after exposure for 1 h to light using red-green-blue (RGB) values of 255, 255, and 255 (average fluence of 49.1 ± 0.6 J/cm2). After 24 h, the cell viability was assessed by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Experimental results showed that exposure of cells treated with verteporfin to the light from the device enhances the drug's cytotoxic effect via a mechanism mediated by reactive oxygen species (ROS). In addition, the use of the prototype described in this work was validated by comparing the results with a commercial PDT device. Thus, this LED-based photodynamic therapy prototype represents a good alternative for in vitro studies of PDT.